참고문헌
- Jaruratanasirikul S, Leethanaporn K, Sriplung H. Thyrotoxicosis in children: treatment and outcome. J Med Assoc Thai 2006;89:967-73.
- Sills IN. Hyperthyroidism. Pediatr Rev 1994;15:417-21.
- Zimmerman D, Lteif AN. Thyrotoxicosis in children. Endocrinol Metab Clin North Am 1998;27:109-26. https://doi.org/10.1016/S0889-8529(05)70302-9
- Zimmerman D, Gan-Gaisano M. Hyperthyroidism in children and adolescents. Pediatr Clin North Am 1990;37:1273-95.
- Stenszky V, Kozma L, Balazs C, Rochlitz S, Bear JC, Farid NR. The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metab 1985;61:735-40. https://doi.org/10.1210/jcem-61-4-735
- Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 2003;24:694-717. https://doi.org/10.1210/er.2002-0030
- Krassas GE, Laron Z. A questionnaire survey concerning the most favourable treatment for Graves' disease in children and adolescents. Eur J Endocrinol 2004;151:155-6. https://doi.org/10.1530/eje.0.1510155
- Webster J, Taback SP, Sellers EA, Dean HJ. Graves' disease in children. Cmaj 2003;169:104-5.
- Gruneiro-Papendieck L, Chiesa A, Finkielstain G, Heinrich JJ. Pediatric Graves' disease: outcome and treatment. J Pediatr Endocrinol Metab 2003;16:1249-55. https://doi.org/10.1515/JPEM.2003.16.9.1249
- Lippe BM, Landaw EM, Kaplan SA. Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. J Clin Endocrinol Metab 1987;64:1241-5. https://doi.org/10.1210/jcem-64-6-1241
- Baker B, Shapiro B, Fig LM, Woodbury D, Sisson JC, Beierwaltes WH. Unusual complications of antithyroid drug therapy: four case reports and review of literature. Thyroidology 1989; 1:17-26.
- Cooper DS, Goldminz D, Levin AA, Ladenson PW, Daniels GH, Molitch ME, et al. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med 1983;98:26-9. https://doi.org/10.7326/0003-4819-98-1-26
- Williams KV, Nayak S, Becker D, Reyes J, Burmeister LA. Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? J Clin Endocrinol Metab 1997;82:1727-33. https://doi.org/10.1210/jc.82.6.1727
- Gorton C, Sadeghi-Nejad A, Senior B. Remission in children with hyperthyroidism treated with propylthiouracil. Long-term results. Am J Dis Child 1987;141:1084-6.
- Rivkees SA, Sklar C, Freemark M. Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998;83:3767-76. https://doi.org/10.1210/jc.83.11.3767
- Benker G, Vitti P, Kahaly G, Raue F, Tegler L, Hirche H, et al. Response to methimazole in Graves' disease. The European Multicenter Study Group. Clin Endocrinol (Oxf) 1995;43: 257-63. https://doi.org/10.1111/j.1365-2265.1995.tb02030.x
- Buckingham BA, Costin G, Roe TF, Weitzman JJ, Kogut MD. Hyperthyroidism in children. A reevaluation of treatment. Am J Dis Child 1981;135:112-7.
- Glaser NS, Styne DM. Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab 1997;82: 1719-26. https://doi.org/10.1210/jc.82.6.1719
- He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, et al. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism. Clin Endocrinol (Oxf) 2004;60:676-81. https://doi.org/10.1111/j.1365-2265.2004.02032.x
- Shulman DI, Muhar I, Jorgensen EV, Diamond FB, Bercu BB, Root AW. Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 1997;7:755-60. https://doi.org/10.1089/thy.1997.7.755
- Allahabadia A, Daykin J, Holder RL, Sheppard MC, Gough SC, Franklyn JA. Age and gender predict the outcome of treatment for Graves' hyperthyroidism. J Clin Endocrinol Metab 2000;85:1038-42. https://doi.org/10.1210/jc.85.3.1038
- Schleusener H, Schwander J, Fischer C, Holle R, Holl G, Badenhoop K, et al. Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol (Copenh) 1989; 120:689-701.
- Young ET, Steel NR, Taylor JJ, Stephenson AM, Stratton A, Holcombe M, et al. Prediction of remission after antithyroid drug treatment in Graves' disease. Q J Med 1988;66:175-89.
피인용 문헌
- The Clinical Course and Prognostic Factors to Medical Treatment of Graves' Disease in Children and Adolescents vol.17, pp.1, 2010, https://doi.org/10.6065/apem.2012.17.1.33
- The Influence of Juvenile Graves' Ophthalmopathy on Graves' Disease Course vol.2017, pp.None, 2010, https://doi.org/10.1155/2017/4853905
- Long-term outcomes of Graves’ disease in children and adolescents receiving antithyroid drugs vol.26, pp.4, 2010, https://doi.org/10.6065/apem.2040286.143
- Commentary on "Long-term outcomes of Graves’ disease in children and adolescents receiving antithyroid drugs" vol.26, pp.4, 2010, https://doi.org/10.6065/apem.2120143edi01